Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: A novel strategy for exploring active components and effective mechanism of TCM formulae. (June 2020)

• Record Type: Journal Article
• Authors: Ding, Zihe; Zhong, Renxing; Yang, Yanni; Xia, Tianyi; Wang, Wujing; Wang, Yi; Xing, Na; Luo, Yun; Li, Shuyuan; Shang, Lifeng; Shu, Zunpeng
• Is Part Of: Pharmacological research. Volume 156(2020)
• Publication Date: 2020-06
• Subjects: Acute lung injury -- The gut-lung axis theory -- Ge-Gen-Qin-Lian decoction -- Systems pharmacology -- PI3K/Akt signaling pathway; Pharmacology -- Periodicals; Pharmacology -- Periodicals; Research -- Periodicals; Médicaments -- Recherche -- Périodiques; Pharmacologie -- Périodiques; 615.105
• DOI: 10.1016/j.phrs.2020.104759
• Languages: English
• ISSNs: 1043-6618

Abstract

Graphical abstract: Highlights: It lays the foundation for the future development of new Chinese medicinal materials (CMM)-based anti-ALI and other drug formulations. It augments the anti-ALI theory of Ge-Gen-Qin-Lian decoction (GQD) and establishes the clinical significance and prospects for development of traditional Chinese medicine (TCM) formula-based treatments for ALI and other disorders. It provides a new approach that uses TCM theory combined with advanced systematic pharmacology technology to study the TCM formula, and overcomes the difficulty of multi-component and multi-target studies of TCM. It skillfully combines pharmacodynamics, network pharmacology, transcriptome, molecular biology, and other disciplines to explore and verify the anti-ALI protective effect and molecular mechanism of GQD at multiple levels. Abstract: Acute lung injury (ALI), a severe and life-threatening inflammation of the lung, with high morbidity and mortality, underscoring the urgent need for novel treatments. Ge-Gen-Qin-Lian decoction (GQD), a classic Chinese herbal formula, has been widely used to treat intestine-related diseases in the clinic for centuries. In recent years, a growing number of studies have found that GQD has a favorable anti-inflammatory effect. With the further study on the viscera microbiota, the link between the lungs and the gut—the gut-lung axis has been established. Based on the theory of the gut-lung axis, we used systems pharmacology to explore the effects and mechanisms of GQD treatment in ALI. Hypothesizing that GQD inhibits ALI progression, we used the experimental model of lipopolysaccharide (LPS)-induced ALI in Balb/c mice to evaluate the therapeutic potential of GQD. Our results showed that GQD exerted protective effects against LPS-induced ALI by reducing pulmonary edema and microvascular permeability. Meanwhile, GQD can downregulate the expression of LPS-induced TNF- α, IL-1 β, and IL-6 in lung tissue, bronchoalveolar lavage fluid (BLAF), and serum. To further understand the molecular mechanism of GQD in the treatment of ALI, we used the network pharmacology to predict the disease targets of the active components of GQD. Lung tissue and serum samples of the mice were separately analyzed by transcriptomics and metabolomics. KEGG pathway analysis of network pharmacology and transcriptomics indicated that PI3K/Akt signaling pathway was significantly enriched, suggesting that it may be the main regulatory pathway for GQD treatment of ALI. By immunohistochemical analysis and apoptosis detection, it was verified that GQD can inhibit ALI apoptosis through PI3K/Akt signaling pathway. Then, we used the PI3K inhibitor LY294002 to block the PI3K/Akt signaling pathway, and reversely verified that the PI3K/Akt signaling pathway is the main pathway of GQD anti-ALI. In addition, differential metabolites in mice serum samples indicate that GQD can inhibit the inflammatory process of ALI by reversing the imbalance of energy metabolism. Our study showed that, GQD did have a better therapeutic effect on ALI, and initially elucidated its molecular mechanism. Thus, GQD could be exploited to develop novel therapeutics for ALI. Moreover, our study also provides a novel strategy to explore active components and effective mechanism of TCM formula combined with TCM theory to treat ALI.